Sulzer proposes InCentive's Braginsky to board
This article was originally published in Clinica
Sulzer Medica is to nominate Rene Braginsky of InCentive Capital to its board of directors. The company is Sulzer Medica's largest shareholder and was responsible for last year's unsuccessful takeover bid for the Swiss company's former parent (see Clinica No 954, p 17). Via the attempt, Mr Braginsky did, however, succeed in his aim of getting Sulzer's medical arm spun off into a separate company, which happened in July 2001.